Why Camp Lejeune is one of the largest mass torts in history
The Camp Lejeune water contamination crisis is one of the largest environmental exposure events in United States military history. For more than three decades -- from 1953 to 1987 -- service members, their families, and civilian employees stationed at Marine Corps Base Camp Lejeune in North Carolina were exposed to drinking water contaminated with volatile organic compounds (VOCs) at concentrations hundreds of times above safe limits.
The passage of the Camp Lejeune Justice Act of 2022, signed into law as part of the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act, opened the door for affected individuals to pursue legal claims against the federal government for the first time. For personal injury attorneys, Camp Lejeune cases represent a massive litigation opportunity with potentially hundreds of thousands of eligible claimants.
Camp Lejeune litigation sits at the intersection of military law, environmental exposure, and mass tort procedure -- creating a defensible specialty with unique procedural requirements that reward attorneys who master the details.
History of water contamination at Camp Lejeune
Marine Corps Base Camp Lejeune, located in Jacksonville, North Carolina, has served as a major East Coast military installation since its establishment in 1942. Between 1953 and 1987, two of the base's primary water treatment plants -- Tarawa Terrace and Hadnot Point -- supplied drinking water contaminated with dangerous levels of industrial solvents and fuel byproducts.
Tarawa Terrace water treatment plant
The contamination at Tarawa Terrace was traced primarily to ABC One-Hour Cleaners, an off-base dry cleaning facility that improperly disposed of industrial solvents. Perchloroethylene (PCE) contamination at this plant reached levels as high as 215 parts per billion (ppb) -- more than 43 times the EPA maximum contaminant level of 5 ppb.
Hadnot Point water treatment plant
The Hadnot Point system served the main side of the base, including barracks, offices, and industrial areas. Contamination here came from on-base sources: leaking underground storage tanks, industrial spills, and waste disposal practices. Trichloroethylene (TCE) was the dominant contaminant, reaching concentrations as high as 1,400 ppb -- 280 times the EPA limit. Benzene, vinyl chloride, and other VOCs were also detected at dangerous levels.
Timeline of discovery and response
Despite the Marine Corps discovering contamination as early as 1982, the affected wells were not shut down until 1985 (Hadnot Point) and 1987 (Tarawa Terrace). Internal documents later revealed that military officials were aware of the contamination risks but delayed public disclosure. The ATSDR began its health studies in 1991 and has continued to publish findings establishing clear links between the contaminated water and serious diseases.
The toxic chemicals found in Camp Lejeune drinking water
The contaminated water at Camp Lejeune contained a cocktail of hazardous chemicals, each with well-documented health effects. Understanding these contaminants is critical for establishing causation in litigation.
| Chemical | Source | Peak PPB | Classification |
|---|---|---|---|
| TCE | Metal degreasing, storage tanks | 1,400 | Carcinogenic to humans (EPA) |
| PCE | Dry cleaning solvents | 215 | Probable carcinogen (IARC 2A) |
| Benzene | Leaking fuel storage tanks | Various | Known carcinogen (IARC 1) |
| Vinyl chloride | TCE/PCE degradation | Various | Known carcinogen (IARC 1) |
Scientific evidence linking contaminated water to disease
The scientific foundation for Camp Lejeune litigation rests on decades of epidemiological research, government health studies, and toxicological analyses. The 2014 ATSDR mortality study found statistically significant increases in deaths from kidney cancer, liver cancer, esophageal cancer, cervical cancer, Hodgkin's lymphoma, and multiple myeloma among Camp Lejeune personnel compared to a control group at Camp Pendleton.
The National Research Council concluded there was "sufficient evidence of a causal relationship" between TCE exposure and kidney cancer, and "limited/suggestive evidence" for several other cancers. The EPA and IARC carcinogenic classifications of each individual chemical further strengthen causation arguments.
Need pre-qualified Camp Lejeune claimants?
Mass Tort Agency delivers exclusive, screened leads directly to your intake team -- veterans, family members, and civilian workers with qualifying conditions.
View Camp Lejeune LeadsThe Camp Lejeune Justice Act of 2022 explained
The Camp Lejeune Justice Act (CLJA) is codified at 28 U.S.C. Section 2214 and represents a landmark shift in how victims of government-caused contamination can seek relief. Prior to its passage, the Federal Tort Claims Act (FTCA) and North Carolina's statute of repose effectively barred most claims.
Key provisions
- Waiver of sovereign immunity: The Act allows individuals to file claims directly against the United States government in the Eastern District of North Carolina.
- Exposure period: Claimants must demonstrate at least 30 days of exposure between August 1, 1953, and December 31, 1987.
- No prior bar: The Act explicitly overrides any statute of limitations or repose defense.
- Administrative exhaustion required: Claimants must first submit a claim to the Department of the Navy. If no settlement is reached within six months, they may file suit.
The PACT Act and its broader implications
The CLJA was enacted as part of the PACT Act, which President Biden signed on August 10, 2022. The PACT Act passed the Senate 86-11 and the House 342-88, reflecting overwhelming bipartisan support. This legislative history signals that Congress found the evidence of harm compelling enough to warrant extraordinary legal relief, creating presumptive conditions for veterans exposed to burn pits, Agent Orange, and other toxic substances.
Who qualifies for a Camp Lejeune lawsuit
Service members
Marines, sailors, soldiers, reservists, and National Guard members who were stationed at Camp Lejeune for 30+ cumulative days between 1953 and 1987.
Family members & dependents
Spouses, children, and dependents who lived in base housing during the contamination period, including children born or conceived at the base.
Civilian workers & contractors
Government employees, contractors, and subcontractors who worked at Camp Lejeune for 30+ days during the covered period.
In utero exposure
Individuals exposed prenatally whose mothers lived or worked at Camp Lejeune while pregnant. Several presumptive conditions relate to prenatal exposure.
Wrongful death claims
Surviving family members may file on behalf of deceased individuals exposed to contaminated water who died from a qualifying condition.
Estate representatives
Estate representatives can pursue wrongful death claims under the CLJA for deceased veterans and family members.
Qualifying medical conditions
The Department of Veterans Affairs and the ATSDR have identified numerous medical conditions associated with exposure to the contaminated water. The VA's list of 15 presumptive conditions represents a government agency's official recognition that these conditions are causally linked to Camp Lejeune water exposure.
Cancer diagnoses
- Kidney cancer: Strongly associated with TCE exposure. The National Academy of Sciences found "sufficient evidence" of causation.
- Liver cancer: Linked to TCE, PCE, and vinyl chloride exposure. Hepatic angiosarcoma is specifically associated with vinyl chloride.
- Non-Hodgkin's lymphoma: Associated with TCE and PCE exposure with multiple epidemiological studies supporting this link.
- Bladder cancer: Linked to PCE and other chlorinated solvent exposure.
- Leukemia: Primarily associated with benzene exposure, a well-established causal relationship.
- Multiple myeloma: Associated with benzene and chlorinated solvent exposure.
- Breast cancer: Linked to TCE and PCE exposure in multiple studies.
- Esophageal cancer: Elevated rates found in ATSDR mortality studies.
- Lung cancer: Associated with chlorinated solvent exposure.
Non-cancer conditions
- Parkinson's disease: Strongly associated with TCE exposure per a 2012 JAMA Neurology study.
- Kidney disease: Chronic exposure to chlorinated solvents damages renal tissue.
- Liver disease: Including hepatic steatosis and other non-cancer liver conditions.
- Systemic sclerosis: An autoimmune condition linked to chlorinated solvent exposure.
- Neurobehavioral effects: Cognitive impairment, memory problems, and neurological symptoms.
- Female infertility and miscarriage: Linked to PCE and TCE exposure in multiple studies.
VA benefits vs. Camp Lejeune lawsuit
Attorneys must understand the distinction between VA healthcare benefits and the civil lawsuit option under the CLJA. Claimants can and should pursue both simultaneously. VA healthcare benefits cover treatment for the 15 presumptive conditions, while a CLJA lawsuit seeks monetary damages including past and future medical expenses, pain and suffering, and lost wages. Any VA disability benefits received will be offset against tort recovery per 28 U.S.C. Section 2214(e).
Current litigation status and case volume
Over 300,000 administrative claims have been filed with the Department of the Navy as of early 2026. Tens of thousands of lawsuits have been filed in the Eastern District of North Carolina, where Judge James C. Dever III has implemented case management procedures including short-form complaints, track assignments based on condition type, and bellwether trial selections.
Track system
Track 1 covers kidney cancer, liver cancer, non-Hodgkin's lymphoma, and leukemia -- conditions with the strongest scientific evidence. Track 2 encompasses bladder cancer, multiple myeloma, and Parkinson's disease. Bellwether trials from these tracks are expected to set the tone for settlement negotiations.
Building a Camp Lejeune practice?
We handle multi-channel claimant acquisition so you can focus on litigation. Exclusive leads, live transfers, custom qualification criteria.
Start Your CampaignSettlement projections and the elective option
| Tier / category | Conditions | Projected range |
|---|---|---|
| Tier 1 (Elective) | Kidney cancer, leukemia (strong exposure) | $400K -- $550K |
| Tier 2 (Elective) | Bladder cancer, multiple myeloma | $200K -- $400K |
| Lower tiers | Less severe conditions, shorter exposure | $100K -- $200K |
| Trial verdicts (projected) | Cancer deaths, strong exposure evidence | $300K -- multi-million |
The DOJ's Elective Option provides pre-set settlement amounts based on the claimant's qualifying condition, exposure duration, and other factors. Claimants who accept the Elective Option receive a guaranteed payment and forgo further litigation. Attorneys should carefully evaluate whether the Elective Option or continued litigation better serves each client's interests.
Building a strong Camp Lejeune case
Successful Camp Lejeune litigation requires systematic evidence gathering. DD-214 discharge documents and service records establish the claimant's presence during the contamination period. For family members, dependent ID cards, base housing records, and school enrollment records demonstrate residence.
Medical causation and expert witness strategies
Medical causation is often the most contested element. Toxicologists testify about the properties of TCE, PCE, benzene, and vinyl chloride and their known health effects. Epidemiologists present population-level studies including the ATSDR mortality and morbidity studies. Treating physicians provide differential diagnosis opinions. Defense experts will raise confounding factors such as smoking, alcohol use, and genetic predisposition.
Common defense arguments
- Alternative causation: The government argues conditions were caused by smoking, family history, or post-service exposures.
- Insufficient exposure: Challenging whether the claimant was present for the required 30-day minimum.
- Latency period: Arguing the time between exposure and disease onset is inconsistent with known latency periods.
- Damages reduction: Seeking to minimize compensation based on advanced age or pre-existing conditions.
How to acquire Camp Lejeune claimants
Effective claimant acquisition requires a multi-channel approach. Pre-qualified Camp Lejeune leads from Mass Tort Agencyprovide a direct pipeline, but firms should also develop veteran community outreach through VFW posts, American Legion chapters, and Marine Corps League groups. Building referral relationships with VA hospitals, oncologists, and neurologists generates additional referrals. Digital marketing campaigns targeting "Camp Lejeune lawsuit" and condition-specific keywords drive qualified traffic nationwide.
Cross-referencing related practice areas
Camp Lejeune claims are a natural extension of any toxic tort practice. Firms active in this area may also benefit from diversifying into related mass torts -- practice areas like AFFF firefighting foam, Roundup cancer, or Ozempic gastroparesis provide revenue stability and a broader client base.
